Anni Aggerholm
Palle Juul Jensens Boulevard 99
Aarhus N, 8200, Denmark
Aarhus N, 8200, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Single-Cell Multi-Omics Identifies Measurable Residual Disease Targets Among Myelodysplasia- and Clonal Hematopoiesis-Related Genes in Acute Myeloid Leukemia.
Journal: Cancers
Published: January 16, 2026
A Danish nationwide population-based cohort study on acute myeloid leukemia with RUNX1::RUNX1T1 - Real-world outcomes and clinicopathological characteristics.
Journal: Blood cancer journal
Published: June 23, 2025
Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups.
Journal: British journal of haematology
Published: October 23, 2021
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Journal: Bone marrow transplantation
Published: June 03, 2021
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments.
Journal: Experimental hematology
Published: May 21, 2021
Measurable Residual Disease Monitoring of SPAG6, ST18, PRAME, and XAGE1A Expression in Peripheral Blood May Detect Imminent Relapse in Childhood Acute Myeloid Leukemia.
Journal: The Journal of molecular diagnostics : JMD
Published: March 09, 2021
Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression.
Journal: Leukemia research
Published: January 28, 2020
GC bias affects genomic and metagenomic reconstructions, underrepresenting GC-poor organisms.
Journal: GigaScience
Published: July 16, 2019
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
Journal: European journal of haematology
Published: February 21, 2019
International external quality assurance of JAK2 V617F quantification.
Journal: Annals of hematology
Published: November 11, 2018
Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy.
Journal: British journal of haematology
Published: August 30, 2018
Last Updated: 09/26/2026